Results 131 to 140 of about 54,991 (287)

Postpartum Depression: Overlap Between Symptom‐Based and Register‐Based Measures

open access: yesActa Psychiatrica Scandinavica, EarlyView.
ABSTRACT Introduction Postpartum depression (PPD) can be measured in various ways, including questionnaire‐based symptom scores or through administrative health databases. We examined the overlap between symptom‐based and register‐based PPD definitions and assessed the consistency in exposure‐outcome associations.
Sofie Egsgaard   +6 more
wiley   +1 more source

New Psychoactive Substances (NPS) Trends in the United States

open access: yesEmerging Trends in Drugs, Addictions, and Health
Introduction: New psychoactive substances (NPS) have continually evolved since appearing in the United States in 2009. The timely dissemination of information outlining the NPS currently in the market provides useful information to the law enforcement ...
E.D. Lockhart
doaj   +1 more source

New psychoactive substances in Australia

open access: yes, 2018
Over the past decade, countries worldwide have observed the rapid emergence of substances collectively referred to as ‘new psychoactive substances’ (NPS). To date, hundreds of NPS have been identified; however, for the most part very little is known about these substances.
openaire   +2 more sources

Effectiveness of a Psychiatrist‐Led Clinic for Metabolic Health in Severe Mental Illness: A Retrospective Chart Review Study

open access: yesActa Psychiatrica Scandinavica, EarlyView.
ABSTRACT Background Psychotropic medications are associated with serious metabolic adverse effects, which contribute to an increased risk of cardiometabolic comorbidities in patients with severe mental illness (SMI). Several intervention strategies are available to mitigate these metabolic adverse effects; however, data on their utility in real‐world ...
Nicolette Stogios   +17 more
wiley   +1 more source

New psychoactive substances: factsheet

open access: yes, 2015
This factsheet has been produced in response to requests from parents and those working with young people for information on 'new psychoactive substances' (NPS).
openaire   +2 more sources

Drug Laws, Ethics, and History [PDF]

open access: yes, 2019
In this paper, I present and criticize several historical arguments in favour of prohibition and criminalization of illicit psychoactive substances. I consider several versions of Charles Brent’s argument from drug harms and an argument
Greif, Adam
core  

Psychiatric History and Postpartum Depression: The Mediating Role of Obstetric Complications

open access: yesActa Psychiatrica Scandinavica, EarlyView.
ABSTRACT Introduction Psychiatric history is the strongest risk factor for postpartum depression (PPD). Obstetric complications, more prevalent among women with a psychiatric history, are also independent risk factors. However, the mechanisms linking these factors to PPD remain unclear.
Mette‐Marie Zacher Kjeldsen   +9 more
wiley   +1 more source

Psychedelic‐assisted treatment for substance use disorder: A narrative systematic review

open access: yesAddiction, EarlyView.
Abstract Background and aims This is the first systematic review of the extant literature on all major psychedelic‐assisted treatment for alcohol use disorder (AUD), tobacco use disorder (TUD) and other substance use disorders (SUD). We aimed to summarise the evidence for efficacy of psychedelic‐assisted treatment for AUD, TUD, and SUD; to evaluate its
Theodore Piper   +7 more
wiley   +1 more source

Technical report on N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3- carboxamide (ADB-CHMINACA). Annex 1 to the Risk Assessment Report on N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1- (cyclohexylmethyl)-1H-indazole-3-carboxamide (ADB-CHMINACA). [PDF]

open access: yes
In accordance with Article 6 of Council Decision 2005/387/JHA on the information exchange, risk assessment and control of new psychoactive ...
Almeida, A   +10 more
core  

Home - About - Disclaimer - Privacy